This invention relates to bioassay platforms, in particular, pull-down assay platforms using silica core-polymerized phospholipid vesicle shell particles for peptide/protein ligand screening. Background: Many physiological or pathological events involve the molecular recognition and binding between a peptide/protein ligand and a specific target on the cell membrane. Certain ligand-receptor binding events trigger corresponding cellular responses, such as enzyme activity and gene expression. Nowadays, screening of peptide/protein ligands that bind to targets on cell membranes is an important process in drug discovery. There is a need for rapid and highly specific assay platforms for identifying novel ligand receptor interactions while minimizing crosstalk and non-specific binding. To address this need this technology provides a novel microparticle architecture that utilizes stabilized vesicle-functionalized microparticles for separations. Applications:
Advantages: